TCRX

News

Tscan Therapeutics Inc (TCRX) receives an Equal-weight rating from Morgan Stanley

Roman Campbell

Tscan Therapeutics Inc’s recently made public that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67 ...

Analysts Viewpoint

An Analysis of Tscan Therapeutics Inc (TCRX)’s Potential Price Growth

Daniel Torres

In a filing, Tscan Therapeutics Inc revealed its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67 ...

Stock Earnings

Tscan Therapeutics Inc [TCRX] Investment Guide: What You Need to Know

Jaxson Clark

Tscan Therapeutics Inc’s filing revealed that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67 million ...

Insiders Updates

The Potential Rise in the Price of Tscan Therapeutics Inc (TCRX) following insiders activity

Daniel Torres

Tscan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67 ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.